- Medafor Ends EDA with CryoLife; Will Take Over Distribution to Cardiac and Vascular Surgery Markets October 8, 2010
- Medafor Records Strong Results for the Second Quarter of 2010 July 27, 2010
- Medafor Refutes False and Misleading Statements Made By CryoLife Regarding Medafor's Unilateral Decision to Resume Shipments of Hemostase July 1, 2010
- Medafor Shareholders Vote Overwhelmingly to Re-Elect Directors at Annual Meeting June 11, 2010
- Settlement of Medafor v. Richard R. Zerban and Steven G. Anderson, et al. April 7, 2010
- Medafor Informs CryoLife that CryoLife Has Repudiated the Exclusive Distribution Agreement March 18, 2010
- Medafor Inc. Signs Long-Term Agreement with Magle Life Sciences March 12, 2010
- Frequently Asked Questions For Medafor Shareholders About CryoLife’s Unsolicited Proposal February 24, 2010
- Shareholder Communication - Response to CryoLife’s Unsolicited Proposal. February 10, 2010
- Shareholder Communication-Initial Response to CryoLife’s Unsolicited Proposal. January 25, 2010
-
Shareholder Communication - Summary of CryoLife
Litigation.
November 23, 2009 *Updated as of April 7th, 2010
FDA Lifts Urological Surgical Restriction for Medafor’s Arista™AH Absorbable Surgical Hemostat
MINNEAPOLIS, July 16, 2007 -- Medafor, Inc., announced today that its Arista™AH Absorbable Hemostat is now available for use in urological surgical procedures. The FDA has removed the restriction on this application of Arista AH from the device indication statement. READ FULL STORY.
FDA Approves Medafor's Arista™AH Absorbable Surgical Hemostat for U.S. Operating Rooms
MINNEAPOLIS, October 3, 2006 -- Medafor, Inc., announced today that its Arista™ AH Absorbable Hemostat has received FDA approval to be marketed within the United States. Arista AH has been distributed internationally since 2002 and has compiled a remarkable record of surgical success around the world. In the U.S., this easy-to-use, efficacious and safe hemostat is indicated for most types of surgery including cardiac, orthopedic, spinal and general surgical applications. READ FULL STORY.
